| Literature DB >> 26546606 |
Andrea Björkman1, Likun Du1, Kerstin Felgentreff2, Cornelia Rosner1, Radhika Pankaj Kamdar1, Georgia Kokaraki1, Yoshihisa Matsumoto3, E Graham Davies4, Mirjam van der Burg5, Luigi D Notarangelo6, Lennart Hammarström1, Qiang Pan-Hammarström7.
Abstract
Nonhomologous end-joining (NHEJ) is one of the major DNA double-strand break repair pathways in mammalian cells and is required for both V(D)J recombination and class switch recombination (CSR), two Ig gene-diversification processes occurring during B cell development. DNA-dependent protein kinase, catalytic subunit (DNA-PKcs) is a component of the classical NHEJ machinery and has a critical function during V(D)J recombination. However, its role in CSR has been controversial. In this study, we examined the pattern of recombination junctions from in vivo-switched B cells from two DNA-PKcs-deficient patients. One of them harbored mutations that did not affect DNA-PKcs kinase activity but caused impaired Artemis activation; the second patient had mutations resulting in diminished DNA-PKcs protein expression and kinase activity. These results were compared with those from DNA-PKcs-deficient mouse B cells. A shift toward the microhomology-based alternative end-joining at the recombination junctions was observed in both human and mouse B cells, suggesting that the classical NHEJ pathway is impaired during CSR when DNA-PKcs is defective. Furthermore, cells from the second patient showed additional or more severe alterations in CSR and/or NHEJ, which may suggest that DNA-PKcs and/or its kinase activity have additional, Artemis-independent functions during these processes.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26546606 DOI: 10.4049/jimmunol.1501633
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422